Literature DB >> 29048659

MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.

Cui-Ping Tang1, Han-Jing Zhou1, Jian Qin1, Yi Luo1, Tao Zhang1.   

Abstract

Interleukin-8 (IL-8), which is secreted by cancer cells undergoing epithelial-mesenchymal transition (EMT), can promote EMT in adjacent epithelial-like cells. MicroRNAs (miRNAs/miRs) can affect the expression of target genes via binding to their 3'-untranslated regions (3'-UTRs), which may subsequently affect the biological behaviors of cancer cells. In our previous study, miR-520c-3p was predicted to directly target the 3'-UTR of IL-8. Therefore, the present study was carried out to investigate whether miR-520c-3p can interact with the IL-8 gene and regulate the EMT of breast cancer cells. Web-based prediction algorithms were used to identify miRNAs that potentially target the IL-8 transcript. Luciferase reporter assays were used to confirm the targeting of IL-8 by miR-520c-3p. Reverse transcription-quantitative PCR and western blot analyses were used to examine the levels of IL-8 and EMT-related genes in breast cancer cells. The functional impact of miR-520c-3p on EMT phenotype was evaluated using Transwell and wound-healing assays, and rescue experiments were conducted by overexpressing IL-8 to determine its effect on cell properties. miR-520c-3p was predicted by all three databases, which strongly suggested its interaction with the 3'-UTR of IL-8. The relative Renilla luciferase activity of luciferase reporter construct containing the wild-type 3'-UTR of IL-8 was markedly decreased by miR-520c-3p transfection when compared with scrambled miRNA control transfection (P<0.001). In addition, compared with the scrambled miRNA control transfection, the overexpression of miR-520c-3p significantly reduced the expression of IL-8, and resulted in increased E-cadherin and decreased vimentin and fibronectin levels in MCF-7 and T47D cells (all P<0.001). Introduction of miR-520c-3p inhibited the invasion and migration of MCF-7 and T47D cells (all P<0.001). By contrast, the rescue of IL-8 expression led to the recovery of EMT-related protein expression patterns and cell motility and invasion capabilities. In conclusion, aberrant miR-520c-3p expression may lead to reduced IL-8 expression and promote the mesenchymal phenotype in breast cancer cells, thereby increasing invasive growth.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29048659     DOI: 10.3892/or.2017.5968

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2.

Authors:  Xin Li; Jinghao Liu; Minghui Liu; Chunqiu Xia; Qingchun Zhao
Journal:  Cell Cycle       Date:  2020-02-27       Impact factor: 4.534

3.  Fibronectin Functions as a Selective Agonist for Distinct Toll-like Receptors in Triple-Negative Breast Cancer.

Authors:  Anthony Ambesi; Pranav Maddali; Paula J McKeown-Longo
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

4.  Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN/AKT/NF-κB axis.

Authors:  Yang Liu; Jingwen Wang; Jianwen Chen; Shaoshuai Wu; Xianhuang Zeng; Qiushuang Xiong; Yandan Guo; Junwei Sun; Feifei Song; Jiaqi Xu; Sen Yuan; Chuang Li; Yuan He; Ming Wang; Lang Chen; Yun-Bo Shi; Mingxiong Guo; Deyin Guo; Guihong Sun
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-20       Impact factor: 10.183

5.  Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells.

Authors:  Yihan Wang; Rui Zhang; Guangqi Cheng; Ruida Xu; Xiaofeng Han
Journal:  Cell Cycle       Date:  2018-08-06       Impact factor: 4.534

6.  Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.

Authors:  Arman Shahabi; Behrooz Naghili; Khalil Ansarin; Maryam Montazeri; Mehdi Dadashpour; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

7.  MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.

Authors:  Chonggao Yin; Qingjie Mou; Xinting Pan; Guoxin Zhang; Hongli Li; Yunbo Sun
Journal:  Thorac Cancer       Date:  2018-03-10       Impact factor: 3.500

8.  FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial- mesenchymal transition through regulation of SLUG.

Authors:  Hui Ye; Meiling Duan
Journal:  Cancer Manag Res       Date:  2019-01-04       Impact factor: 3.989

9.  MiR-942 regulates the function of breast cancer cell by targeting FOXA2.

Authors:  Jinku Zhang; Zhiqiang Zhang; Jirui Sun; Qiushuang Ma; Wenming Zhao; Xue Chen; Haizhi Qiao
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

10.  miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A.

Authors:  Xiaohan Sun; Wenrui Xu; Chuanshan Zang; Na Li
Journal:  Oncol Lett       Date:  2019-11-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.